Egido J, Robles A, Ortiz A, Ramirez F, Gonzalez E, Mampaso F, Sanchez Crespo M, Braquet P, Hernando L
Eur J Pharmacol. 1987 Jun 12;138(1):119-23. doi: 10.1016/0014-2999(87)90346-3.
The effect of steroids, heparin and specific PAF-acether antagonists (BN 52021 and triazolobenzodiazepines) on proteinuria and renal histological changes induced in rats by adriamycin was studied. Adriamycin evoked a marked proteinuria that was unaffected by methylprednisolone and slightly reduced by heparin. In contrast, adriamycin-injected rats treated with PAF-acether antagonists had a low proteinuria, if any, and no ultrastructural glomerular alterations. These data suggest that PAF-acether could play a major role in the occurrence of proteinuria and that PAF-acether antagonists might provide a new therapeutic approach in certain human nephropathies.
研究了类固醇、肝素和特异性血小板活化因子乙酰水解酶拮抗剂(BN 52021和三唑并苯二氮䓬类)对阿霉素诱导的大鼠蛋白尿和肾脏组织学变化的影响。阿霉素诱发了显著的蛋白尿,甲基强的松龙对此无影响,肝素使其略有降低。相反,用血小板活化因子乙酰水解酶拮抗剂治疗的注射阿霉素的大鼠,即使有蛋白尿也很低,且肾小球无超微结构改变。这些数据表明,血小板活化因子乙酰水解酶可能在蛋白尿的发生中起主要作用,且血小板活化因子乙酰水解酶拮抗剂可能为某些人类肾病提供一种新的治疗方法。